SEC Form 4 · accession 0000899243-17-017605
AILERON THERAPEUTICS INC · ALRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald Dougherty
Officer — SVP & Chief Financial Officer
Period of report
Jun 28, 2017
Accepted (ET)
Jun 30, 2017 · 1:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $15.00 | Jun 28, 2017 | A | 140,887 | A | — | Jun 28, 2027 | Common Stock | 140,887 | 140,887 | D |
Explanation of responses
- F1These options were granted on June 28, 2017 and vest as to 25% of the shares on June 8, 2018 and vest thereafter as to 2.0833% of the shares in equal monthly installments through June 8, 2021.